Megumi Iwai
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical Pharmacokinetics, Mass Balance and Metabolism of Fezolinetant in Postmenopausal Women.
Journal: European journal of drug metabolism and pharmacokinetics
Published: October 31, 2025
Quantitative Systems Toxicology Modeling with DILIsym to Support Phase 3 Dose Selection for Fezolinetant.
Journal: Clinical pharmacology and therapeutics
Published: August 04, 2025
Concentration-QTc Modeling to Support Clinical Development of Fezolinetant.
Journal: Clinical pharmacology in drug development
Published: June 23, 2025
Pharmacokinetics and Safety of Fezolinetant in Women with Hepatic or Renal Impairment.
Journal: Journal of clinical pharmacology
Published: April 04, 2025
Pharmacokinetics, Tolerability, and Biomarker Profile of the Neurokinin 3 Receptor Antagonist Fezolinetant in Healthy Japanese Individuals: A 2-Part, Randomized, Phase 1 Study.
Journal: Clinical pharmacology in drug development
Published: March 26, 2025
Pharmacokinetics of Bocidelpar, ASP0367, in Renal and Hepatic Impairment: Results From Two Phase 1 Studies.
Journal: Clinical and translational science
Published: March 24, 2025
Physiologically Based Pharmacokinetic (PBPK) Model to Predict the Magnitude of Drug-Drug Interaction Between Fezolinetant and CYP1A2 Inhibitors.
Journal: Journal of clinical pharmacology
Published: February 06, 2025
An Open-Label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects.
Journal: Drug design, development and therapy
Published: September 23, 2024
In Vitro Evaluation of CYP-Mediated Metabolism of Fezolinetant and Pharmacokinetic Interaction Between Fezolinetant and Fluvoxamine in Healthy Postmenopausal Smokers and Nonsmokers.
Journal: Journal of clinical pharmacology
Published: August 15, 2024
Progressive Resistance Training Improves Torque Capacity and Strength in Mobility-Limited Older Adults.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: December 19, 2017
Utility of P-glycoprotein and organic cation transporter 1 double-transfected LLC-PK1 cells for studying the interaction of YM155 monobromide, novel small-molecule survivin suppressant, with P-glycoprotein.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: September 16, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026